Impact of the 24-h ultramarathon race on homocysteine, oxidized low-density lipoprotein, and paraoxonase 1 levels in professional runners

PLoS One. 2018 Feb 2;13(2):e0192392. doi: 10.1371/journal.pone.0192392. eCollection 2018.

Abstract

The impact of the 24-h ultramarathon race on homocysteine (Hcy) and oxidized low-density lipoprotein (oxLDL) levels, two well-recognized cardiovascular risk factors, has not been deeply investigated. Similarly, no information exists on paraoxonase 1 (PON1), an antioxidant enzyme associated with high-density lipoproteins, which may detoxify oxLDL and Hcy-thiolactone, hence preventing their proatherogenic action. Taking this into account, a competitive 24-h ultramarathon race was organized in Reggio-Emilia (Italy) recruiting professional runners (n = 14) from the Italian Ultramarathon and Trail Association. Blood samples were collected from each participant before, during (14 h), and immediately after (24 h) the competition, thus to monitor the serum changes in Hcy, oxLDL, and PON1 levels, as well as other oxidative stress-related parameters, namely reactive oxygen metabolites (ROM) and total antioxidant capacity (PAT). As a result, a significant PON1 increase was recorded after 14 h of racing that persisted until the end of the performance. The same trend was observed for PAT values, which positively correlated to PON1 levels (R = 0.643, P<0.001). Hcy, oxLDL, and ROM remained almost unchanged throughout the competition. In conclusion, the present study suggested a protective role of PON1 in sustaining the antioxidant defense system and contrasting lipoprotein oxidative modifications over the 24-h race, and did not specifically evidence either Hcy or oxLDL accumulation in such challenging sporting events.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aryldialkylphosphatase / blood*
  • Female
  • Homocysteine / blood*
  • Humans
  • Italy
  • Lipoproteins, LDL / blood*
  • Male
  • Middle Aged
  • Running*

Substances

  • Lipoproteins, LDL
  • oxidized low density lipoprotein
  • Homocysteine
  • Aryldialkylphosphatase

Grants and funding

This study was partially sustained by Centro di Terapia Riabilitativa “C.T.R.” (Reggio Emilia, Italy). The funder had no role in data collection and analysis. There was no additional external funding received for this study. Other sources of support were internal to our organization